2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine has been researched along with Reperfusion Injury in 1 studies
2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine: a selective inhibitor of nitric oxide synthase; structure given in first source
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, SQ | 1 |
| Ye, JS | 1 |
| Zong, YY | 1 |
| Sun, CC | 1 |
| Liu, DH | 1 |
| Wu, YP | 1 |
| Song, T | 1 |
| Zhang, GY | 1 |
1 other study available for 2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine and Reperfusion Injury
| Article | Year |
|---|---|
S-nitrosylation of mixed lineage kinase 3 contributes to its activation after cerebral ischemia.
Topics: Animals; Brain Ischemia; Dizocilpine Maleate; Enzyme Activation; Enzyme Inhibitors; HEK293 Cells; Hu | 2012 |